Pages that link to "Q35665486"

The following pages link to The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. (Q35665486):

Displaying 48 items.

• The role of bile acids in metabolic regulation (Q26770807) (← links)
• Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective. (Q27693345) (← links)
• Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome (Q28070321) (← links)
• Causality of small and large intestinal microbiota in weight regulation and insulin resistance (Q28828501) (← links)
• Gut-Brain Cross-Talk in Metabolic Control (Q30235568) (← links)
• Endoscopic Bariatric and Metabolic Therapies: Surgical Analogues and Mechanisms of Action (Q30240029) (← links)
• Obesity: Current and potential pharmacotherapeutics and targets (Q30243992) (← links)
• The gut microbiota and gastrointestinal surgery (Q36161048) (← links)
• Treatment of Obesity: Weight Loss and Bariatric Surgery (Q36956145) (← links)
• Obesity and Asthma: Microbiome-Metabolome Interactions (Q37088255) (← links)
• Non-alcoholic fatty liver disease and diabetes (Q37091659) (← links)
• Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Q37206402) (← links)
• Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery (Q37550281) (← links)
• The ratio of dihomo-γ-linolenic acid to deoxycholic acid species is a potential biomarker for the metabolic abnormalities in obesity. (Q38288183) (← links)
• Metabolic Mechanisms in Obesity and Type 2 Diabetes: Insights from Bariatric/Metabolic Surgery. (Q38638560) (← links)
• The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (Q38656970) (← links)
• Targeting the gut to treat obesity and its metabolic comorbidities: focus on bariatric surgery - view from the chair (Q38690163) (← links)
• Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype? (Q38714369) (← links)
• Attenuated Effects of Bile Acids on Glucose Metabolism and Insulin Sensitivity in a Male Mouse Model of Prenatal Undernutrition. (Q38715299) (← links)
• The Sleeping Remnant. Effect of Roux-En-Y Gastric Bypass on Plasma Levels of Gastric Biomarkers in Morbidly Obese Women: A Prospective Longitudinal Study (Q38784216) (← links)
• The crosstalk between gut microbiota and obesity and related metabolic disorders (Q38837418) (← links)
• Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB. (Q39047697) (← links)
• Biological control of appetite: A daunting complexity (Q39147573) (← links)
• Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota (Q42356646) (← links)
• Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. (Q46561979) (← links)
• Changes in total energy intake and macronutrient composition after bariatric surgery predict long-term weight outcome: findings from the Swedish Obese Subjects (SOS) study (Q47212548) (← links)
• Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA. (Q47660505) (← links)
• A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy (Q48035253) (← links)
• An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults (Q48141171) (← links)
• Roux-en-Y Gastric-Bypass and sleeve gastrectomy induces specific shifts of the gut microbiota without altering the metabolism of bile acids in the intestinal lumen (Q49911829) (← links)
• Is a Simple Food-Diverting Operation the Solution for Type 2 Diabetes Treatment? Experimental Study in a Non-Obese Rat Model (Q51297760) (← links)
• Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery. (Q53784109) (← links)
• In Silico Analysis Identifies Intestinal Transit as a Key Determinant of Systemic Bile Acid Metabolism. (Q55333816) (← links)
• Antibiotic treatment of rat dams affects bacterial colonization and causes decreased weight gain in pups (Q57075066) (← links)
• Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis (Q57108591) (← links)
• Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial (Q57115133) (← links)
• Metabolic Surgery and Diabesity: a Systematic Review (Q57116100) (← links)
• Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs (Q57129815) (← links)
• Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome (Q60047622) (← links)
• The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss. (Q64976609) (← links)
• Sleeve Gastrectomy and Diabetes: Is Cure Possible? (Q88742473) (← links)
• Taste Changes after Bariatric Surgery: a Systematic Review (Q90654965) (← links)
• Long-term diabetes outcomes after bariatric surgery-managing medication withdrawl (Q91272392) (← links)
• Metabolic phenotyping of the human microbiome (Q91869803) (← links)
• Gut Peptide Agonism in the Treatment of Obesity and Diabetes (Q92106443) (← links)
• Reversing Type 2 Diabetes: A Narrative Review of the Evidence (Q92795184) (← links)
• Ozone-induced changes in the serum metabolome: Role of the microbiome (Q92901096) (← links)
• Cholecystectomy - a potential selection bias in studies assessing the metabolic effects of bariatric surgeries (Q96817067) (← links)